Marth C, Weger A, Müller-Holzner E, Zeimet A G, Moncayo-Naveda H, Daxenbichler G, Reibnegger G, Fuchs D, Wachter H, Dapunt O
Department of Obstetrics and Gynecology, Innsbruck University Hospital, Austria.
Eur J Cancer. 1993;29A(13):1863-8. doi: 10.1016/0959-8049(93)90539-r.
The prognostic value of clinical factors, morphometric features and neopterin, a marker for macrophage activation, was investigated retrospectively in 68 ovarian carcinoma patients. Nuclear roundness was a good predictor of patient survival. About 50% of our patients showed neopterin concentrations above the cut-off level of 275 mumol/mol creatinine. Interestingly, those patients with elevated urinary neopterin concentration, and thus displaying a sign of activation of cell-mediated immunity, had a shorter survival than those with normal concentration. Applying a multivariate Cox regression analysis, the only independent parameters predicting patient survival were FIGO stage, residual disease, nuclear roundness and neopterin.